Faruqi & Faruqi, LLP Announces Investigation of Pharmaceutical Product Development Inc.
October 04 2011 - 7:00PM
Business Wire
Faruqi & Faruqi, LLP, a leading national securities firm
headquartered in New York City, is investigating the Board of
Directors of Pharmaceutical Product Development Inc. (“PPD” or the
“Company”) (NASDAQ: PPDI) for potential breaches of fiduciary
duties in connection with their conduct related to the sale of the
Company to the Carlyle Group and Hellman & Friedman LP in an
all-cash deal valued at about $3.79 billion. Under the terms of the
proposed transaction, PPD’s stockholders will receive $33.25 in
cash per each share of PPD they own, while according to Yahoo!
Finance, at least one financial analyst has set a price target of
$38 for PPD.
Request more information now by clicking here:
www.faruqilaw.com/PPDI
Whether PPD’s Board of Directors breached their fiduciary duties
to the Company’s stockholders by failing to conduct an adequate and
fair sales process prior to agreeing to this proposed transaction,
whether the proposed transaction undervalues PPD’s shares and by
how much this proposed transaction undervalues the Company to the
detriment of PPD’s shareholders are the key focus of this
investigation.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The firm is
focused on providing exemplary legal services in complex litigation
in the areas of securities, shareholder, antitrust and consumer
litigation, throughout all phases of litigation. The firm has an
experienced trial team which has achieved significant victories on
behalf of the firm’s clients.
If you own common stock in PPD and wish to obtain additional
information, please visit us at www.faruqilaw.com/PPDI or contact
Juan E. Monteverde, Esq. either via e-mail at
jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or
(212) 983-9330.
Attorney Advertising. (C) 2011 Faruqi & Faruqi, LLP. The law
firm responsible for this advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We are happy to
discuss your particular case.
Pharmaceutical Product Developme (NASDAQ:PPDI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pharmaceutical Product Developme (NASDAQ:PPDI)
Historical Stock Chart
From Apr 2023 to Apr 2024